Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- SAGB-PMIndependent statistical analysis of Post Implantation/Post Market Evaluation of the Swedish Adjustable Gastric Band: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00543140).
- SAGEIndependent statistical analysis of Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02539459).
- SAGEIndependent statistical analysis of Effect of a Two-month Carbohydrate-restricted Diet on Energy Metabolism in a Seniors' Residence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SAHA + CHOP in Untreated T-cell Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00787527).
- SAIA-HTNIndependent statistical analysis of Systems Analysis and Improvement Approach for the Hypertension Care Cascade: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04088656).
- SAILIndependent statistical analysis of Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SAILIndependent statistical analysis of Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01687179).
- SAILIndependent statistical analysis of Sustained Aeration of Infant Lungs Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02139800).
- SAILINGComplete statistical analysis of the SAILING phase 3 trial comparing GSK1349572 (dolutegravir) with raltegravir in antiretroviral-experienced, integrase inhibitor-naive adults with HIV infection, including its non-inferiority design, Cochran-Mantel-Haenszel analysis, risk difference, confidence interval,…
- SAKURAIndependent statistical analysis of Study to Investigate the Efficacy of Symbicort® SMART.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00839800).
- SALIFIndependent statistical analysis of A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment: primary endpoint results,…
- Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SALPIndependent statistical analysis of Pilot Study to Determine Effects of Salsalate in Type 1 Diabetes and Painful Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Salsalate as an Adjunctive Treatment for Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Salsalate as an Adjunctive Treatment for Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01578486).
- Salsalate for Insulin Resistance in Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Salsalate for Insulin Resistance in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01182727).
- SALTIndependent statistical analysis of Isotonic Solution Administration Logistical Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02345486).
- SALTIndependent statistical analysis of Steroids After Laser Trabeculoplasty for Glaucoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00981435).
- Salt to GrowIndependent statistical analysis of Physiologic Approach to Sodium Supplementation in Premature Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03889197).
- SALUDIndependent statistical analysis of Self-Administered Lidocaine Gel for Pain Management With IUD Insertion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02738203).
- SAMIndependent statistical analysis of Sensory Augmentation Methods in Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03988400).
- SAMIndependent statistical analysis of Sustained Acoustic Medicine (SAM) Combined With a Diclofenac Ultrasound Coupling Patch for Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SAMBAIndependent statistical analysis of Severe Asthma, MepolizumaB and Affect: SAMBA Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04680611).
- Same Day Discharge After Minimally-invasive Sacrocolpopexy: Complete Statistical AnalysisIndependent statistical analysis of Same Day Discharge After Minimally-invasive Sacrocolpopexy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03730103).
- SAMMPRISIndependent statistical analysis of Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SAMSIndependent statistical analysis of Supervised Asthma Medication in Schools (SAMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01997463).
- SAMURAIComplete statistical analysis of the phase 3 SAMURAI trial of lasmiditan versus placebo for acute migraine, including trial design, binary endpoints, logistic regression, odds ratios, confidence intervals, p-values, safety, and interpretation.
- Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) Trial: Complete Statistical AnalysisIndependent statistical analysis of Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01178827).
- Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial: Complete Statistical AnalysisIndependent statistical analysis of Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00863551).
- SANDPIPERIndependent statistical analysis of A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase…
- SANICSIIIndependent statistical analysis of SANICS II Trial: Stimulation of the Autonomic Nervous System in Colorectal Surgery by Perioperative Nutrition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly: Complete Statistical AnalysisIndependent statistical analysis of Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03312231).
- Sanofi H1N1 + TIV – Adults and Elderly: Complete Statistical AnalysisIndependent statistical analysis of Sanofi H1N1 + TIV - Adults and Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00943878).
- Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations: Complete Statistical AnalysisIndependent statistical analysis of Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery: primary endpoint results, effect estimate with confidence interval, sample-size…
- SAPHEIndependent statistical analysis of Somatuline Autogel Preference and Health Economy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00681187).
- Saphenous Nerve Block for Foot and Ankle Surgery: Complete Statistical AnalysisIndependent statistical analysis of Saphenous Nerve Block for Foot and Ankle Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02382744).
- Saphenous Nerve Block vs. Femoral Nerve Block for Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Saphenous Nerve Block vs. Femoral Nerve Block for Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SAPPHIREIndependent statistical analysis of Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SAPPHIREIndependent statistical analysis of Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03001414).
- SAPPHIRE PhAIndependent statistical analysis of SEARCH SAPPHIRE Phase A: A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SARA-INTIndependent statistical analysis of A Double-blind, Placebo-controlled, Randomized INTerventional Clinical Trial (SARA-INT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03452488).
- Saracatinib and Alcohol Drinking: Complete Statistical AnalysisIndependent statistical analysis of Saracatinib and Alcohol Drinking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02955186).
- Saracatinib in Treating Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Saracatinib in Treating Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01267266).
- Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors: Complete Statistical AnalysisIndependent statistical analysis of SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SARCAIndependent statistical analysis of Lansoprazole to Treat Children With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00442013).
- Sarizotan in Participants With Parkinson’s Disease Suffering From Treatment Associated Dyskinesia: Complete Statistical AnalysisIndependent statistical analysis of Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SARONAPLUSIndependent statistical analysis of Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SARS-CoV-2 Human Challenge Characterisation Study: Complete Statistical AnalysisIndependent statistical analysis of SARS-CoV-2 Human Challenge Characterisation Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04865237).
- SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation: Complete Statistical AnalysisIndependent statistical analysis of SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04631705).